Receptor-interacting protein shuttles between cell death and survival signaling pathways

Molecular Biology of the Cell

Volumn 21, Issue 3, 2010, Pages 481-488

  Kamarajan, Pachiyappan ^a   Bunek, Julius ^a   Lin, Yong ^b   Nunez, Gabriel ^c   Kapila, Yvonne L ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FOCAL ADHESION KINASE; PROTEIN; RECEPTOR INTERACTING PROTEIN; UNCLASSIFIED DRUG;

ANOIKIS; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD95; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; FAS LIGAND PROTEIN; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MICE; MICE, KNOCKOUT; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION;

EID: 76049123040     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E09-06-0530     Document Type: Article

References (41)

1. Aronsohn, M. S., Brown, H. M., Hauptman, G., and Kornberg, L. J. (2003). Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx. Laryngoscope 113, 1944-1948.
2. Barkalow, F. J., and Schwarzbauer, J. E. (1991). Localization of the major heparin-binding site in fibronectin. J. Biol. Chem. 266, 7812-7818.
3. Cusson, N., Oikemus, S., Kilpatrick, E. D., Cunningham, L., and Kelliher, M. (2002). The death domain kinase RIP protects thymocytes from tumor necrosis factor receptor type 2-induced cell death. J. Exp. Med. 196, 15-26.
4. Devin, A., Lin, Y., and Liu, Z. G. (2003). The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases. EMBO Rep. 4, 623-627.
5. Duxbury, M. S., Ito, H., Zinner, M. J., Ashley, S. W., and Whang, E. E. (2004). Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. Surgery 135, 555-562.
6. Friesen, C., Herr, I., Krammer, P. H., and Debatin, K. M. (1996). Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med. 2, 574-577.
7. Frisch, S. M., and Francis, H. (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124, 619-626.
8. Frisch, S. M., Vuori, K., Ruoslahti, E., and Chan-Hui, P. Y. (1996). Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol. 134, 793-799.
9. Habib, A. A., Chatterjee, S., Park, S. K., Ratan, R. R., Lefebvre, S., and Vartanian, T. (2001). The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa B (NF-kappa B)-inducing kinase to activate NF-kappa B. Identification of a novel receptor-tyrosine kinase signalosome. J. Biol. Chem. 276, 8865-8874.
10. Inohara, N., Koseki, T., Lin, J., del Peso, L., Lucas, P. C., Chen, F. F., Ogura, Y., and Nunez, G. (2000). An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275, 27823-27831.
11. Jackson-Bernitsas, D. G., Ichikawa, H., Takata, Y., Myers, J. N., Lin, X. L., Dar nay, B. G., Chattered, M. M., and Agarwal, B. B. (2007). Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappa activation and proliferation in human head and neck squamous cell carcinoma. Oncogene 26, 1385-1397.
12. Joo, N. E., Watanabe, T., Chen, C., Cheken ya, M., Stall cup, W. B., and Kapila, Y. L. (2008). NG2, a novel proapoptotic receptor, opposes integrin alpha4 to mediate anoikis through PKCalpha-dependent suppression of FAK phosphorylation. Cell Death Differ. 15, 899-907.
13. Kamarajan, P., and Kapila, Y. L. (2007). An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK. Apoptosis 12, 2221-2231.
14. Kapila, Y. L., Niu, J., and Johnson, P. W. (1997). The high affinity heparinbinding domain and the V region of fibronectin mediate invasion of human oral squamous cell carcinoma cells in vitro. J. Biol. Chem. 272, 18932-18938.
15. Kapila, Y. L., Wang, S., and Johnson, P. W. (1999). Mutations in the heparin binding domain of fibronectin in cooperation with the V region induce decreases in pp125(FAK) levels plus proteoglycan-mediated apoptosis via caspases. J. Biol. Chem. 274, 30906-30913.
16. Kelliher, M. A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B. Z., and Leder, P. (1998). The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8, 297-303.
17. Krammer, P. H. (1999). CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv. Immunol. 71, 163-210.
18. Krammer, P. H. (2000). CD95's deadly mission in the immune system. Nature 407, 789-795.
19. Kurenova, E., Xu, L. H., Yang, X., Baldwin, A. S., Jr., Craven, R. J., Hanks, S. K., Liu, Z. G., and Cance, W. G. (2004). Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein. Mol. Cell. Biol. 24, 4361-4371.
20. Lin, Y., Devin, A., Cook, A., Keane, M. M., Kelliher, M., Lipkowitz, S., and Liu, Z. G. (2000). The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase. Mol. Cell. Biol. 20, 6638-6645.
21. Lin, Y., Devin, A., Rodriguez, Y., and Liu, Z. G. (1999). Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 13, 2514-2526.
22. Lin, Y., Yang, Q., Wang, X., and Liu, Z. G. (2006). The essential role of the death domain kinase receptor-interacting protein in insulin growth factor-Iinduced c-Jun N-terminal kinase activation. J. Biol. Chem. 281, 23525-23532.
23. Martinon, F., Holler, N., Richard, C., and Tschopp, J. (2000). Activation of a pro-apoptotic amplification loop through inhibition of NF-kappaB-dependent survival signals by caspase-mediated inactivation of RIP. FEBS Lett. 468, 134-136.
24. Meylan, E., and Tschopp, J. (2005). The RIP kinases: crucial integrators of cellular stress. Trends Biochem. Sci. 30, 151-159.
25. Miyazaki, T., Kato, H., Nakajima, M., Sohda, M., Fukai, Y., Masuda, N., Manda, R., Fukuchi, M., Tsukada, K., and Kuwano, H. (2003). FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br. J. Cancer 89, 140-145.
26. Moers, C., Warskulat, U., Muschen, M., Even, J., Niederacher, D., Josien, R., Koldovsky, U., Beckmann, M. W., and Haussinger, D. (1999). Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin. Int. J. Cancer 80, 564-572.
27. Owens, L. V., Xu, L., Craven, R. J., Dent, G. A., Weiner, T. M., Kornberg, L., Liu, E. T., and Cance, W. G. (1995). Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 55, 2752-2755.
28. Parsons, J. T. (2003). Focal adhesion kinase: the first ten years. J. Cell Sci. 116, 1409-1416.
29. Peter, M. E., and Krammer, P. H. (1998). Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr. Opin. Immunol. 10, 545-551.
30. Schaller, M. D. (2001). Paxillin: a focal adhesion-associated adaptor protein. Oncogene 20, 6459-6472.
31. Schlaepfer, D. D., Hanks, S. K., Hunter, T., and van der Geer, P. (1994). Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372, 786-791.
32. Shibakita, M., Tachibana, M., Dhar, D. K., Kotoh, T., Kinugasa, S., Kubota, H., Masunaga, R., and Nagasue, N. (1999). Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer. Clin. Cancer Res. 5, 2464-2469.
33. Stanger, B. Z., Leder, P., Lee, T. H., Kim, E., and Seed, B. (1995). RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81, 513-523.
34. Tafolla, E., Wang, S., Wong, B., Leong, J., and Kapila, Y. L. (2005). JNK1 and JNK2 oppositely regulate p53 in signaling linked to apoptosis triggered by an altered fibronectin matrix: JNK links FAK and p53. J. Biol. Chem. 280, 19992-19999.
35. Thakar, J., Schleinkofer, K., Borner, C., and Dandekar, T. (2006). RIP death domain structural interactions implicated in TNF-mediated proliferation and survival. Proteins 63, 413-423.
36. Uslu, R., Borsellino, N., Frost, P., Garban, H., Ng, C. P., Mizutani, Y., Belldegrun, A., and Bonavida, B. (1997). Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis. Clin. Cancer Res. 3, 963-972.
37. Vega, M. I., Huerta-Yepez, S., Jazirehi, A. R., Garban, H., and Bonavida, B. (2005). Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fasinduced apoptosis. Oncogene 24, 8114-8127.
38. Wang, C. Y., Mayo, M. W., and Baldwin, A. S., Jr. (1996). TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274, 784-787.
39. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., and Baldwin, A. S., Jr. (1998). NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683.
40. Xu, L. H., Owens, L. V., Sturge, G. C., Yang, X., Liu, E. T., Craven, R. J., and Cance, W. G. (1996). Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ. 7, 413-418.
41. Zhang, Y., Lu, H., Dazin, P., and Kapila, Y. (2004). Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin alphav mediate survival signals through focal adhesion kinase. J. Biol. Chem. 279, 48342-48349.